Schering-Plough's CEO Fred Hassan said Wednesday that the prices being fetched in the recent wave of big pharmaceutical takeover bids are "breath-taking," and are reflective of how difficult it is for large companies to acquire quality drug candidates.
"The prices that are being paid by our competitors are breath-taking," said Hassan, in an interview with MarketWatch on Wednesday. "They would've been unthinkable five years ago."
Er, Fred, welcome to the world of being gouged over drug prices.
Now you might understand how your customers have been feeling for some time!
No comments:
Post a Comment